Top Pharmaceutical Companies (2,037)
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and autoimmune diseases.
JAMP Pharma Group is a private Canadian company founded in 1988, originally a contract manufacturing organization. It is a leading generic player in the Canadian pharmaceutical industry, providing high-quality, affordable medicines and health solutions.
ApotheCom is a Global Medical Communications Powerhouse with offices in London, Leeds, Yardley, New York, San Francisco, San Diego, Boston, Lebanon, Auckland, Tokyo and Johannesburg. Our mission is to be an effective and proactive broker of collaborative and sustained engagement for the healthcare community, to drive meaningful change and positive outcomes. ApotheCom is uniquely able to create and deploy teams...
Founded in 1898, Roswell Park Comprehensive Cancer Center is the first institution in the world to focus exclusively on cancer research. As the only NCI-designated comprehensive cancer center in Upstate New York, it integrates world-class cancer care, research, and education. The center is dedicated to leading breakthroughs in oncology and delivering compassionate, patient-centered care to thousands of patients globally.
Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorder and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to...
Vireo Health is a physician-led company dedicated to providing patients with best-in-class cannabis-based products and high quality care
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic...
We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
Xeris Pharmaceuticals's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is portrayed as rising sharply year over year, with multiple references to double‑digit quarterly increases and a step-up from 2024 to 2025. Guidance for 2026 indicates continued expansion, reinforcing a trajectory of sustained top-line gains.
Profitability: Statements indicate a transition toward financial sustainability, including reports of positive net income and Adjusted EBITDA in 2025. This suggests improving earnings quality alongside revenue growth.
Strong Market Position & Advantage: Observations highlight a specialized leadership in nonaqueous, ready-to-use injectable formulations through XeriSol and XeriJect. Commercial traction for Gvoke within its niche supports a defensible position in targeted segments.
Cosmos Limited is a leading pharmaceutical company based in Nairobi, Kenya, that has been manufacturing high-quality human and veterinary products since 1978. The company is committed to providing exceptional pharmaceutical care, expert advice, and a comprehensive range of quality and affordable medicines to patients across Kenya and East Africa.
Grand River Aseptic Manufacturing (GRAM) is a leading pharmaceutical contract development and manufacturing organization (CDMO) specializing in aseptic fill-finish services for biologics, small molecules, and vaccines, offering capabilities for liquid and lyophilized vials, syringes, and cartridges.
Delphon Industries is a global provider of engineered polymer and adhesive products specializing in high-end material solutions for the semiconductor, photonics, medical, and electronics industries. Founded in 1982, the company develops device protection and adhesive solutions through its brands Gel-Pak, TouchMark, and UltraTape, serving over 2,500 customers worldwide with highly engineered materials and advanced manufacturing technologies.
At Endo, our far-reaching vision is simple: to help everyone we serve live their best life. As a specialty pharmaceutical company, we’re motivated by a strong sense of purpose to find better ways to meet unique medical needs. Our global team of passionate employees understands the importance of their work. We’re dedicated to supporting one another as we connect with communities...
Endo's Top Stability & Growth Strengths
Strong Market Position & Advantage: Xiaflex is the only FDA‑approved nonsurgical therapy for Peyronie’s disease and an FDA‑approved option for Dupuytren’s contracture, giving the franchise clear category leadership within this narrow segment. Marketing continued into 2025 with national campaigns reinforcing this positioning.
Product Line Growth: Xiaflex posted record 2024 sales and grew again in Q1 2025, with the Branded segment up in the quarter. New sterile injectable launches (e.g., ADRENALIN ready‑to‑use premixed bags) add to near‑term product momentum.
Future-Ready Strategy: The April 2024 emergence from Chapter 11 reduced debt and removed significant litigation overhang, enabling renewed focus on branded growth and selected sterile injectables. Management reaffirmed 2025 guidance implying stabilization with potential slight growth and announced portfolio‑reshaping moves including a combination with Mallinckrodt and an international divestiture.
Since 2014, Vimachem has been transforming pharmaceutical and biotech manufacturing with the AI-powered, composable Vimachem Pharma MES Platform. Purpose-built for the Life Sciences industry, the platform has been deployed across 200+ pharma sites globally, helping manufacturers boost process efficiency, enhance product quality, and reduce compliance risk and lead times. Smart, flexible, and built with the pharma operator in mind, the Vimachem...
Purex Health Care is an Egyptian pharmaceutical and cosmeceutical company dedicated to enhancing health outcomes and improving the quality of life.
Our mission at ARS Pharmaceuticals is to provide at-risk patients and their families better protection from severe allergic reactions. We are developing a product that patients and their caregivers can use without anxiety or hesitation, confident in the effectiveness of the both product and the ability to administer it. We are developing ARS-1, a novel intranasal epinephrine spray with a unique...
QuVa Pharma is a leader in 503B outsourced compounding, serving all 50 states with a full portfolio of sterile, ready-to-administer injectable products. QuVa was purpose-built to change the 503B industry for the better and is leading the way in making it more safe, efficient, and reliable. With unmatched expertise in cGMPs and sterile pharmaceutical manufacturing, we achieve higher than required...
Neu-Ion, Inc. is a women-owned, family-run business that designs, builds, installs, and services high-purity water treatment systems. They provide tailored solutions for a variety of critical industries, including biotechnology, pharmaceuticals, healthcare, research, and industrial facilities. Specializing in the design and preventive maintenance of high-purity water systems, they ensure operational consistency, regulatory compliance, and long-term performance for their clients across the...
